The global biosimilars market size was valued at USD 20.44 billion in 2022 and is projected to grow from USD 23.96 billion in 2023 to USD 73.03 billion by 2030, exhibiting a CAGR of 17.3% during the forecast period. Europe dominated the global market with a share of 50.44% in 2022.

Market Overview

The  ****is experiencing transformative growth, driven by healthcare technology innovations, expanding digital ecosystems, and a rising focus on preventive and personalized medicine. Between 2022 and 2030, the industry is projected to expand significantly, supported by higher healthcare budgets, evolving patient expectations, and growing investments in infrastructure and research.

Demographic shifts—including aging populations, urbanization, and the rising prevalence of chronic diseases—are further accelerating demand for advanced healthcare services and solutions worldwide.

represents a broad set of products, solutions, and services that enhance care delivery, improve safety, and ensure compliance. These solutions are crucial for reducing risks, protecting patients, enhancing diagnostic and treatment efficiency, and maintaining regulatory adherence.

Continue reading for more details:

https://www.fortunebusinessinsights.com/biosimilars-market-108928

Key Market Drivers

1. Rising Patient Safety Concerns – Demand for tools that prevent medical errors and infections.
2. Technological Advancements – Integration of AI, analytics, and automation for efficiency.
3. Healthcare Expenditure Growth – Investments in infrastructure upgrades by governments and private players.
4. Regulatory Pressure – Strict global safety standards driving adoption.
5. Expansion in Emerging Markets – Improved healthcare infrastructure in Asia-Pacific, Latin America, and Africa.

Market Segmentation

The  can be segmented as follows:

• 1. Market Analysis, Insights and Forecast – By Drug Class
     1. Filgrastim & Peg-filgrastim
     2. Monoclonal Antibodies
     3. Others
  5. Market Analysis, Insights and Forecast – By Disease Indication
     1. Cancer
     2. Autoimmune Diseases
        1. Arthritis
        2. Psoriasis
        3. Others
     3. Others
  12. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  16. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa

Competitive Landscape

The market is highly competitive, with multinational corporations and regional players adopting strategies such as: